22nd Annual Research Day
Call for Abstract Submission
The Ontario Association on Developmental Disabilities (OADD) Research Special Interest Group (RSIG) is inviting proposals for presentations and posters for its annual research conference, to be held Friday April 11th, 2014 at the Ambassador Conference Resort, 1550 Princess Street, Kingston, Ontario.
RSIG was formed to provide an opportunity for researchers, professionals, and other interested individuals working in the field of developmental disabilities to exchange research, ideas, resources, and concerns.
The objectives of the RSIG meeting are:
To update research advances in the field of intellectual/developmental disabilities and exchange information regarding ongoing research activities.
To provide opportunity for networking and collaboration for researchers and students with an interest in intellectual/developmental disabilities from across the province.
To discuss ways to stimulate interest and support for research at the level of institutions, governments, and research funding bodies.
For more information about OADD and RSIG, please visit: www.oadd.org
We welcome research from all disciplines and areas of research related to developmental disabilities.
Faxed or mailed submissions will not be accepted. You will receive an email confirming that we have received your abstract.
To submit a presentation or poster, please use this form to submit an abstract for the 2014 OADD-RSIG Annual Conference. Prior to submitting your abstract, please ensure that your abstract is consistent with the RSIG guidelines (see below).
Submission Deadline: January 17th, 2014
Abstract Review Process
Abstracts will be reviewed anonymously (i.e., identifying information will be removed) by the conference committee using the guidelines presented below. The review process will be completed by the end of January 2014, and authors will be notified immediately thereafter by email. Note that any abstract that does not meet these standards will not be accepted.
2014 GUIDELINES FOR ABSTRACT SUBMISSIONS
Abstracts should be no more than 500 words in length (word count does not include Title, Authors’ names, or Correspondence section)
Authors are asked to divide their abstract into four sections:
State the purpose of the research and/or any hypotheses tested.
A brief description of the sample (e.g., number of participants; characteristics of participants such as age, diagnosis, severity of intellectual/developmental disability), measures, techniques, and statistics used.
A summary of the findings related to the objectives of the study. If you have pending results, remember to make note of that in your abstract.
Statement addressing the relevance and/or implications of the findings (i.e., how findings apply to real-world issues and inform practice).
- Abstracts should be typed with single spacing, using 11 point Arial font, and 1 inch margins
- Centre the title and type it entirely in CAPITALS and BOLD.
- Please skip a line and include author names and institutional affiliations (in bold, non-capitals, centered). DO NOT list street addresses underneath the title.
- Leave a line before beginning the abstract. Underneath the abstract, leave 5 lines and type in bold, non-capitals, non-centered Correspondence: list contact name, affiliation and email address of at least one author.
RSIG COMMITTEE GUIDELINES FOR REVIEWING ABSTRACTS
The following criteria will be used to score abstracts for poster and oral presentations. Each area is rated on a 4-point scale (0=Not acceptable, 1=Acceptable, 2=Good, and 3=Excellent) for a total score of 15.
Is the purpose or objective of the study clearly stated?
Is the rationale for the project made clear?
Do the authors describe the demographics of the participants adequately?
Is the methodology (e.g., techniques, data, measures, and statistics) described in sufficient detail?
Do the experimental techniques (e.g., standardized measures, etc.) aid in addressing the key research questions and hypotheses?
Did the authors use standardized measures/measures with adequate psychometric properties?
For single-subject design: Are data collected on the reliability or inter-observer agreement (IOA) for each dependent variable?
Are the results presented in a clear, coherent fashion?
Do the results verify or contradict previous findings/theories?
If research is in progress, do the authors describe study progress to date or preliminary results?
Is the conclusion clear and understandable?
Have potential limitations of the methodology been addressed?
Clinical/Research Implications & Novelty
Is the information clinically important, relevant and/or significant?
What are the practical implications of the information?
Is this research original?
We also strongly encourage individual to nominate or apply for OADD-RSIG Awards.